Conferences
9 September 2021, Online
Cancers Webinar | Biomarkers for Cancer Immunotherapy
I would like to welcome you to the Cancers Webinar on Biomarkers of Cancer Immunotherapy. As I’m sure you are aware, novel immunotherapy approaches have had a huge impact in improving cancer outcomes and survival, and immunotherapy is now often referred to as the “fourth pillar” of cancer therapeutics along with surgery, radiation, and chemotherapy. While immunotherapy approaches have provided researchers, clinicians, and patients with new hope for defeating this disease, patient responses to immunotherapies vary widely, and much work remains to be done. One of the key questions to address for improved therapeutic outcomes is which patients will respond to which therapies and why? A number of biomarkers have emerged in recent years to help guide clinicians with cancer immunotherapies, and more are being identified and validated every day. In this webinar, we will hear from two leaders in this field, Dr. Eric Tartour (Hôpital Européen Georges-Pompidou) and Dr. Elin Gray (Edith Cowan University), who will give us their insights on how biomarkers can help improve immunotherapeutic treatment regimens for cancer patients.
The following experts will present and speak:
- Prof. Dr. Carlos S. Moreno, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
- Dr. med. Eric Tartour, 1. Equipe Labellisée Ligue contre le Cancer, 75006 Paris, France, 2. Immunology, APHP, Hôpital Europeen Georges Pompidou, 75006 Paris, France, 3. Université de Paris, PARCC, INSERM U970, 75006 Paris, France
- Prof. Dr. Elin S. Gray, School of Medical and Health Sciences, Edith Cowan University, Joondalup WA 6027, Australia
When? 9 September 2021 at 5:00pm CEST | 11:00am EDT | 11:00pm CST Asia
Click here to register now!
Interested in contributing to the topic? You can find the Special Issue(s) linked to this topic and open for submission by clicking here.
